喘康速治疗支气管哮喘的临床研究

THE CLINICAL RESEARCH OF BRICASOL IN TREATMENT OF BRONCAIHL ASTHAM

支气管哮喘是一种由多种炎性细胞参与的以气道变应性炎（AAI）和气道高反应性（BHR）为特征的疾病，喘康速作为一种高选择性β2受体激动剂，具有起效快，作用时间长，副作用小等特点。本文旨在对喘康造的临床疗效作初步的探讨。

The bronchinl astham is caused by many kinds of inflammatory cells and mediators. Its feature is broncho - hyperreactivity (BHR) and allergic airway inflammation (AAI). As a high -selected β2 - adrenoceptor's agonist , Bricasol affects fast, continues a long time, and rarely has any side effects. This axticle is to study the clinical curative effect of Bricasol.